These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1868244)

  • 1. Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.
    Miller CB; Zehnbauer BA; Piantadosi S; Rowley SD; Jones RJ
    Blood; 1991 Aug; 78(4):1125-31. PubMed ID: 1868244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
    Yeager AM; Rowley SD; Kaizer H; Santos GW
    Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL
    Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
    Lenarsky C; Weinberg K; Petersen J; Nolta J; Brooks J; Annett G; Kohn D; Parkman R
    Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].
    Klingemann HG; Grigg AP; Wilkie-Boyd K; Barnett MJ; Eaves AC; Reece DE; Shepherd JD; Phillips GL
    Blood; 1991 Dec; 78(12):3306-11. PubMed ID: 1742491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of autologous and allogeneic bone marrow transplantation in children with acute leukemia.
    Ohira M; Takayama J
    Acta Paediatr Jpn; 1991 Aug; 33(4):558-63. PubMed ID: 1792916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
    Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
    Smith BD; Jones RJ; Lee SM; Piantadosi S; Vala MS; Fuller D; Gore SD; Noga SJ; O'Donnell PV; Braine H; Vogelsang GB; Fuchs EJ; Flinn IW; Brodsky RA; Ambinder RF; Miller CB
    Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM; Yeager AM
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.
    Uckun FM; Kersey JH; Vallera DA; Ledbetter JA; Weisdorf D; Myers DE; Haake R; Ramsay NK
    Blood; 1990 Nov; 76(9):1723-33. PubMed ID: 2224122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.
    Jones RJ; Zuehlsdorf M; Rowley SD; Hilton J; Santos GW; Sensenbrenner LL; Colvin OM
    Blood; 1987 Nov; 70(5):1490-4. PubMed ID: 3311205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Little evidence for clonal evolution of malignant haematopoietic cells following relapse after autologous bone marrow transplantation.
    Jørgensen H; Hokland P; Jensen AW; Hokland M
    Eur J Haematol; 1996 Jul; 57(1):25-32. PubMed ID: 8698127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
    Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
    Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.
    Shipounova IN; Petinati NA; Bigildeev AE; Drize NJ; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
    Leuk Lymphoma; 2017 Feb; 58(2):408-417. PubMed ID: 27244369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.